胆囊癌的辅助化疗:当前的证据,争议和未来的方向
Jin-Wei Dai1,2, Yi-Xuan Xing2,3, Nian-Zhe Sun2,4
1Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
World journal of gastrointestinal surgery
|September 15, 2025
概括
辅助化疗并没有改善单独接受手术的第二阶段胆囊癌患者的生存率. 这一发现质疑术后化疗的常规使用,影响了对这种侵袭性恶性瘤的临床决策和指导方针.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 胆囊癌带来了重大的治疗挑战,预后不佳,即使在早期阶段也是如此.
- 对于第二阶段胆囊癌的手术后辅助化疗的疗效仍然是一个有争议的话题,证据不一致.
- 缺乏明确的指导方针导致不同的临床实践和依赖其他胆道癌症的数据.
研究的目的:
- 调查辅助化疗对第二阶段胆囊癌患者的生存结果的影响.
- 为了评估在这个特定的患者群体中,将化疗添加到手术干预的有效性.
- 为了解决围绕第二阶段胆囊癌术后化疗的争议.
主要方法:
- 这是一项回顾性队列研究,利用了来自国家癌症数据库的数据.
- 包括明确的标准和明确的治疗分类来选择患者.
- 分析比较了接受单独手术和接受辅助化疗手术的患者之间的生存结果.
主要成果:
- 与单独手术相比,辅助化疗在第二阶段胆囊癌中没有显著的生存益处.
- 这些发现挑战了在这种患者群体中进行手术后化疗的常规管理.
- 结果表明需要重新考虑当前的治疗方法,并可能修订临床指南.
结论:
- 对于第二阶段胆囊癌术后常规使用辅助化疗,这项研究的结果并不支持.
- 临床医生应该重新评估所有患者的术后化疗的必要性.
- 需要进行进一步的严格研究,以建立基于证据的指导方针来管理第二阶段的胆囊癌.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Chronic Pancreatitis II: Collaborative Care
315
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
315
Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Gallbladder
2.0K
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
2.0K

